We are the leading funder of brain tumour research in the UK, spending over £18.3 million to date on pioneering projects that will help adults and children with brain tumours.
We spend 80p in every £1 donated on our charitable aims, so the more we raise, the more we will invest in research. We fund research through a competitive, fair and transparent process of best practice called peer review to ensure we only select the very best research that will have a real impact on those affected by brain tumours.
This research involves innovative approaches that could change our understanding, diagnosis and management of brain tumours.
This research acknowledges the importance of international and interdisciplinary team approaches to accelerate research.
This scheme has been established to focus research onto reducing the burden and harm to those diagnosed with a brain tumour.
We're partnering with the Structural Genomics Consoritum, funding two researchers who will be searching for new drugs.
We want to improve patient outcomes by ensuring early and accurate diagnosis.
We want to catalyse the translation of discoveries made in the lab to clinical benefits for patients.
We want to improve quality of life for all affected by brain tumours and ensure high quality care.
We want to accelerate progress in research by increasing the collection of and access to brain tumour tissue.
Improving our understanding of the biology behind brain tumours is essential to the development of new treatments.
The field of brain tumour research is greatly varied. We fund many researchers, all with different expertise.
We fund research to improve survival rates and reduce the harm caused by brain tumours, all led by our research strategy.
We link to and work with a range of partners to maximise our reach and make sure every penny raised works as hard as possible